Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Briggs

Showing results (421-430 of 475) with videos related to

Pageof 48
Sort By:
Nature Microbiology|September 22, 2019
Author Correction: A surface endogalactanase in Bacteroides thetaiotaomicron confers keystone status for arabinogalactan degradationAlan Cartmell, Jose Muñoz-Muñoz, Jonathon A Briggs, et al.
Acta Neuropathologica|June 21, 2017
Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficitsAlain Lacampagne, Xiaoping Liu, Steven Reiken, et al.
Nature Microbiology|October 24, 2018
A surface endogalactanase in Bacteroides thetaiotaomicron confers keystone status for arabinogalactan degradationAlan Cartmell, Jose Muñoz-Muñoz, Jonathon A Briggs, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2012
Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinomaTrevor J Grant, Joshua A Bishop, Lisa M Christadore, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2008
Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonistsGiancarlo Trani, Stuart M Baddeley, Michael A Briggs, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
Quantitative and stoichiometric analysis of the microRNA content of exosomesJohn R Chevillet, Qing Kang, Ingrid K Ruf, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective propertiesJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.
Nature Communications|June 27, 2015
Glycan complexity dictates microbial resource allocation in the large intestineArtur Rogowski, Jonathon A Briggs, Jennifer C Mortimer, et al.
JCI Insight|March 13, 2020
Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutationEmmanuel Martin, Norbert Minet, Anne-Claire Boschat, et al.
Journal of Medicinal Chemistry|March 4, 1998
Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptorsM W Holladay, J T Wasicak, N H Lin, et al.
Pageof 48

Showing results (421-430 of 475) with videos related to

Sort By:
Pageof 48
Nature Microbiology|September 22, 2019
Author Correction: A surface endogalactanase in Bacteroides thetaiotaomicron confers keystone status for arabinogalactan degradationAlan Cartmell, Jose Muñoz-Muñoz, Jonathon A Briggs, et al.
Acta Neuropathologica|June 21, 2017
Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficitsAlain Lacampagne, Xiaoping Liu, Steven Reiken, et al.
Nature Microbiology|October 24, 2018
A surface endogalactanase in Bacteroides thetaiotaomicron confers keystone status for arabinogalactan degradationAlan Cartmell, Jose Muñoz-Muñoz, Jonathon A Briggs, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 8, 2012
Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinomaTrevor J Grant, Joshua A Bishop, Lisa M Christadore, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2008
Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonistsGiancarlo Trani, Stuart M Baddeley, Michael A Briggs, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 2014
Quantitative and stoichiometric analysis of the microRNA content of exosomesJohn R Chevillet, Qing Kang, Ingrid K Ruf, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective propertiesJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.
Nature Communications|June 27, 2015
Glycan complexity dictates microbial resource allocation in the large intestineArtur Rogowski, Jonathon A Briggs, Jennifer C Mortimer, et al.
JCI Insight|March 13, 2020
Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutationEmmanuel Martin, Norbert Minet, Anne-Claire Boschat, et al.
Journal of Medicinal Chemistry|March 4, 1998
Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptorsM W Holladay, J T Wasicak, N H Lin, et al.
Pageof 48